SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
21-Nov-22 9:30 AM View: | Aytu Biopharma, Inc (AYTU) | 18-Nov-22 | Grant | 90,000 | $0.23 | $20,700.00 | 90% 100.0K to 190.0K | |
19-Jan-22 11:42 AM View: | Aytu Biopharma, Inc (AYTU) | 17-Jan-22 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
18-Nov-19 4:51 PM View: | VIVUS Inc. (VVUS) | 14-Nov-19 | Grant | 700 | $2.38 | $1,666.00 | 6% 11.4K to 12.1K | |
15-May-19 4:59 PM View: | VIVUS Inc. (VVUS) | 14-May-19 | Grant | 700 | $2.84 | $1,988.00 | 7% 10.7K to 11.4K | |
16-Nov-18 4:14 PM View: | VIVUS Inc. (VVUS) | 14-Nov-18 | Grant | 700 | $2.71 | $1,897.00 | 7% 10.0K to 10.7K | |
07-Nov-18 4:10 PM View: | VIVUS Inc. (VVUS) | 06-Nov-18 | Market Purchase | 10,000 | $4.07 | $40,700.00 | 100% 0 to 10.0K | 25% |
02-Apr-13 5:32 PM View: | Alexza Pharmaceuticals Inc. (ALXA) | 29-Mar-13 | Grant | 43,750 | $4.42 | $193,375.00 | 756% 5.79K to 49.54K | (78%) |
29-Aug-12 5:25 PM View: | Alexza Pharmaceuticals Inc. (ALXA) | 27-Aug-12 | Market Sale (Planned) | 10,000 | $4.14 | $41,364.00 | (73%) 13.79K to 3.79K | 77% |
08-Jun-12 4:51 PM View: | Alexza Pharmaceuticals Inc. (ALXA) | 06-Jun-12 | Market Sale (Planned) | 31,873 | $0.34 | $10,776.30 | (19%) 169.77K to 137.9K | 72% |
14-May-12 4:51 PM View: | Alexza Pharmaceuticals Inc. (ALXA) | 10-May-12 | Grant | 100,000 | -- | -- | 143% 69.77K to 169.77K | |
26-Mar-12 5:50 PM View: | Alexza Pharmaceuticals Inc. (ALXA) | 23-Mar-12 | Grant | 31,873 | -- | -- | 84% 37.9K to 69.77K |